University of Illinois and University of Iowa have developed a new treatment that can potentially help all types of cystic fibrosis, regardless of genetic mutation. The potential treatment uses a drug originally used to treat fungal infection to help individuals with the lifelong disease. The cystic fibrosis team consists of University LAS professor Martin Burke and graduate students Katrina Muraglia and Rajeev Chorghade, collaborating with Mike Welsh from the University of Iowa.